IRIS
MAZZOCCA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.621
EU - Europa 762
AS - Asia 445
SA - Sud America 3
OC - Oceania 1
Totale 4.832
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.613
CN - Cina 290
SE - Svezia 231
IT - Italia 121
SG - Singapore 119
DE - Germania 107
RU - Federazione Russa 75
FI - Finlandia 64
UA - Ucraina 50
GB - Regno Unito 48
FR - Francia 21
BE - Belgio 19
VN - Vietnam 16
IE - Irlanda 8
IR - Iran 7
CA - Canada 6
LT - Lituania 5
IN - India 4
NL - Olanda 4
AE - Emirati Arabi Uniti 3
ES - Italia 3
BR - Brasile 2
MX - Messico 2
NO - Norvegia 2
SA - Arabia Saudita 2
AM - Armenia 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
HK - Hong Kong 1
IL - Israele 1
JP - Giappone 1
LU - Lussemburgo 1
LV - Lettonia 1
PL - Polonia 1
Totale 4.832
Salva come PNG Salva come JPEG
Città #
Fairfield 529
Woodbridge 443
Chandler 336
Houston 336
Ashburn 267
Seattle 237
Nyköping 196
Cambridge 190
Wilmington 182
Jacksonville 156
Ann Arbor 150
Singapore 102
Lawrence 64
Roxbury 62
Nanjing 56
Beijing 54
Des Moines 42
Bari 39
New York 34
Inglewood 31
Princeton 30
Santa Clara 23
Brooklyn 22
Dearborn 22
Shenyang 21
Boardman 20
Brussels 18
San Diego 17
Dong Ket 16
Los Angeles 16
Helsinki 15
Jiaxing 15
Nanchang 15
Hebei 13
Paris 12
Zhengzhou 12
Jinan 10
Ningbo 9
Ostuni 9
San Mateo 9
Tianjin 9
Changsha 8
Dublin 8
Guangzhou 8
London 8
Norwalk 8
Leawood 7
Redwood City 7
Taizhou 7
Ardabil 6
Hangzhou 6
Mottola 6
Munich 6
Toronto 6
Shanghai 5
Monmouth Junction 4
Taranto 4
Augusta 3
Grafing 3
Matera 3
Milan 3
Pescara 3
San Francisco 3
Strasbourg 3
Weihai 3
Wuhan 3
Acton 2
Arona 2
Castellana Grotte 2
Chianciano Terme 2
Haidian 2
Hefei 2
Hounslow 2
Indiana 2
Kilburn 2
Kunming 2
Lecce 2
Nürnberg 2
Prato 2
Prescot 2
Quzhou 2
Recife 2
Riyadh 2
Rome 2
Southend 2
Villaromagnano 2
Washington 2
Adelfia 1
Ajman 1
Alghero 1
Altamura 1
Atlanta 1
Berlin 1
Bitonto 1
Bologna 1
Boydton 1
Chicago 1
Chiswick 1
Edinburgh 1
Falkenstein 1
Totale 4.025
Salva come PNG Salva come JPEG
Nome #
null 131
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 122
Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D 120
Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer 117
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 116
Autotaxin is a novel molecular identifier of type I endometrial cancer 111
T(14;18) translocation in chronic hepatitis C virus infection 110
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 108
Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells 107
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. 107
Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment 106
Circulating levels of PAI-1 and SERPINE1 4G/4G polymorphism are predictive of poor prognosis in HCC patients undergoing TACE 102
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates 99
Moving the systemic evolutionary approach to cancer forward: Therapeutic implications 99
null 98
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates 97
Clinical Usefulness of Cancer Antigen 15-3 in Breast Cancer Patients Before and After Surgery 95
Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology 94
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer 88
Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond 87
Sorafenib: 10 years after the first pivotal trial 87
The integrin, α6β1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells 87
Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration 85
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors 84
A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigm 82
cAMP-dependent protein kinase of mitochondria. Structure and possible role of the substrates 78
Tetraspanin-enriched microdomains and hepatocellular carcinoma progression. 77
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. 77
Pathobiology of Hepatocellular Carcinoma and Clinical Impact 77
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells 75
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 74
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions 74
The metastatic process: methodological advances and pharmacological challenges 73
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link? 71
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells 70
Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular Carcinoma 70
Tetraspanins CD9 and CD81 are molecular partners of trimeric FcεRI on human antigen-presenting cells 69
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study 67
Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines 67
Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro 67
Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer 65
The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer. 64
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 61
The TGF-β signaling pathway as a pharmacological target in hepatocellular carcinoma 61
Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 60
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer 58
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 57
Inhibiting TGF-β signaling in hepatocellular carcinoma 56
Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer 56
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function 56
Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin 55
Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L 55
cAMP-dependent protein kinase of mitochondria structure and possible role of the substrates 53
1H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth 52
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease 51
Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection 49
Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation 49
Synergism of adipocytokine profile and ADIPOQ/TNF-α polymorphisms in NAFLD-associated mets predict colorectal liver metastases outgrowth 49
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 48
cAMP-dependent protein kinase of mitochondria structure and possible role of the substrates 47
Targeting TGF-βRI inhibits activation of β1 integrin and blocks vascular invasion in Hepatocellular Carcinoma (HCC) 41
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma 34
The perplexity of targeting genetic alterations in hepatocellular carcinoma 32
Frictional purpuric eruption associated with angiotensin II receptor blockers 30
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth 30
Implications of the lysophosphatidic acid signaling axis in liver cancer 21
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells. 19
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 19
Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis 18
Effect of change of interleukin-6 over time on gait speed response: Results from the lifestyle interventions and independence for elders study 18
Characterization of circulating endothelial cells in Hereditary Haemorrhagic Telangiectasia 13
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 10
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice 8
Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance 7
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy 7
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma 7
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy 6
Crithmum maritimum Improves Sorafenib Sensitivity by Decreasing Lactic Acid Fermentation and Inducing a Pro-Hepatocyte Marker Profile in Hepatocellular Carcinoma 6
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 5
The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic Cancer 4
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 3
Totale 5.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020670 0 0 0 0 0 85 113 116 136 67 117 36
2020/2021877 63 59 43 99 100 105 49 65 51 118 78 47
2021/2022485 17 61 5 15 34 30 28 26 34 24 93 118
2022/2023835 126 109 69 70 95 98 10 100 113 4 30 11
2023/2024251 24 51 15 29 18 59 8 9 1 7 11 19
2024/2025353 28 16 100 51 48 110 0 0 0 0 0 0
Totale 5.065